Carregant...
SARS-CoV-2 vaccination in IBD: past lessons, current evidence and future challenges
Since the beginning of the pandemic, patients with inflammatory bowel diseases (IBD) have been considered at high-risk for infection and complications of COVID-19. However, IBD patients and patients taking immunosuppressive therapy were excluded from clinical phase III vaccine trials, complicating t...
Guardat en:
| Publicat a: | J Crohns Colitis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989537/ https://ncbi.nlm.nih.gov/pubmed/33721882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjab046 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|